The injection of estradiol valerate in female rats induces polycystic ovary syndrome, which is characterized by polycystic ovaries, anovulation, and hyperandrogenism. These characteristics have been associated with an increase in the ovarian concentration of norepinephrine, which occurs before establishing the polycystic ovary syndrome. The bilateral section of the superior ovarian nerve restores ovarian functions in animals with polycystic ovary syndrome. The superior ovarian nerve provides norepinephrine and vasoactive intestinal peptide to the ovary. An increase in the activity of both neurotransmitters has been associated with the development of polycystic ovary syndrome. The purpose of the present study was analyzed the participation of the noradrenergic nervous system in the development of polycystic ovary syndrome using guanethidine as a pharmacological tool that destroys peripheral noradrenergic nerve fibers.
Fourteen-day old female rats of the CIIZ-V strain were injected with estradiol valerate or vehicle solution. Rats were randomly allotted to one of three guanethidine treatment groups for denervation: 1) guanethidine treatment at age 7 to 27-days, 2) guanethidine treatment at age 14 to 34- days, and 3) guanethidine treatment at age 70 to 90- days. All animals were sacrificed when presenting vaginal oestrus at age 90 to 94-days. The parameters analyzed were the number of ova shed by ovulating animals, the ovulation rate (i.e., the numbers of ovulating animals/the numbers of used animals), the serum concentration of progesterone, testosterone, oestradiol and the immunoreactivity for tyrosine hydroxylase enzyme. All data were analyzed statistically. A p-value of less than 0.05 was considered significant.
Our results show that the elimination of noradrenergic fibers before the establishment of polycystic ovary syndrome prevents two characteristics of the syndrome, blocking of ovulation and hyperandrogenism. We also found that in animals that have already developed polycystic ovary syndrome, sympathetic denervation restores ovulatory capacity, but it was not as efficient in reducing hyperandrogenism.
The results of the present study suggest that the noradrenergic fibers play a stimulant role in the establishment of polycystic ovary syndrome.
Franks S. Polycystic ovary syndrome in adolescents. Int J Obes. 2008;32:1035–41. CrossRef
Franks S. Polycystic ovary syndrome. Med Prog. 1995;333:853–61.
Morales AJ, Laughlin GA, Bützow T, et al. Insulin, somatotropic, and LH axes in lean and obese women with polycystic ovay syndrome: common and distinct features. J Clin Endocrinol Metab. 1996;81:2854. PubMed
Hull MGR. The causes of infertility and relative effectiveness of treatment. In: Tepleton AA, Drife JO, editors. Infertility. London: Springer-Verlag; 1992. p. 33–62. CrossRef
Taylor AE, Mccourt B, Martin KA, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82(7):2248–56. PubMed
Chávez R, Carrizosa L, Domínguez R. Effects of superior ovarian nerve on spontaneous and induced ovulation in adult rats. Med Sci Res. 1991;19:41–8.
Morales-Ledesma L, Linares R, Rosas G, et al. Unilateral sectioning of the superior ovarian nerve of rats with polycystic ovarian syndrome restores ovulation in the innervated ovary. Reprod Biol Endocrinol. 2010;8(99):1–7.
Lansdown A, Rees A. The sympathetic nervous system in polycycstic ovary syndrome: a novel therapeutic target? Clin Endocrinil. 2012;77:791–801. CrossRef
Parra C, Fiedler JL, Luna SL, Greiner M, Padmanabhan V, Lara HE. Participation of vasoactive intestinal polypeptide in ovarian steroids production during the rat estrous cycle and in the development of estradiol valerate-induced polycystic ovary. Soc Reprod Fertil. 2007;133:147–54. CrossRef
Jensen-Holm J, Juul P. Ultrastructural changes in the rat superior cervical ganglion following prolonged guanethidine administration. Acta Pharmacol Toxicol. 1971;30:308–20. CrossRef
Linares R, Hernández D, Morán C, et al. Unilateral or bilateral vagotomy induces ovulation in both ovaries of rats with polycystic ovarian syndrome. Reprod Biol Endocrinol. 2013;11(68):1–9.
Dissen GA, Ojeda SR. Ovarian Innervation. Enc Reprod. 1999;3:583–9.
Burnstock G, Evans B, Gannon BJ, Heath JW, James V. A new method of destroying adrenergic nerves in adult animals using guanethidine. Br J Pharmac. 1971;43:295–301. CrossRef
Heath JW, Evan BK, Gannon BJ, Burnstock G, James VB. Degeneration of adrenergic neurons following guanethidine treatment: an ultrastructural study. Virchows Archly Abteilung B-Zellpathologie. 1972;11:182–97.
Eränkö L, Eränkö O. Effect of guanethidine on nerve cells and small intensely fluorescent cells in sympathetic ganglia of newborn and adult rats. Acta Pharmacol Toxicol. 1971;30:403–16. CrossRef
Manni L, Holmäng A, Lundeberg T, Aloe L, Stener-Victorin E. Ovarian expression of alpha (1)- and beta (2)-adrenoceptors and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries. Auton Neurosci Basic Clin. 2005;118:79–87. CrossRef
Sverrisdottir YB, Mogren T, Kataoka J, Janson PO. Stener-Victorin E. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab. 2008;294:576–81. CrossRef
Yen SSC. Síndrome del ovario poliquístico (Anovulación crónica hiperandrogénica). In: Yen SSC, Vela P, Rankin J, editors. Médica Panamericana S. A. Buenos Aires; 2001. p. 465–509.
Morales L, Chávez R, Domínguez R. Participation of the superior ovarian nerve in the regulation of ovulation in the prepuberal rat: differential effects of unilateral and bilateral section of the nerve. Med Sci Res. 1993;21:15–7.
Flores A, Ayala ME, Domínguez R. Does noradrenergic peripheral innervation have a different role in the regulation of ovulation in the prepubertal and the adult rat? Med Sci Res. 1990;18:817–8.
Morales-Ledesma L, Vieyra E, Ramírez D, et al. Effects on steroid hormones secretion resulting from the acute stimulation of sectioning the superior ovarian nerve to pre-puberal rats. Reprod Biol Endocrinol. 2012;10(88):1–7.
Abad-Santos F, Novalbos J, García AG. Sístema nervioso simpático: fármacos simpaticolíticos. In: Lorenzo- Velázquez B, Lorenzo P, Moreno A, et al., editors. Médica Panamericana S. A. Buenos Aires; 2008. p. 178.
- Pharmacological sympathetic denervation prevents the development of polycystic ovarian syndrome in rats injected with estradiol valerate
Julieta A. Espinoza
- BioMed Central
Neu im Fachgebiet Gynäkologie und Geburtshilfe
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II